Detalhe da pesquisa
1.
Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII). / Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE Coalition COVID-19 Brazil VIII).
Arq Bras Cardiol
; 120(3): e20220431, 2023 03.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-37018790
2.
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.
Lancet Reg Health Am
; 11: 100243, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378952
3.
Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE - Coalition COVID-19 Brazil VIII) / Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII)
Arq. bras. cardiol
; 120(3): e20220431, 2023. tab, graf
Artigo
em Português
|
LILACS-Express
| ID: biblio-1429790